ZBH Stock Analysis: Buy, Sell, or Hold?
ZBH - Zimmer Biomet Holdings, Inc.
$100.98
2.01 (2.03%)
▲
5d:
+0.33%
30d:
+12.64%
90d:
+18.37%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When ZBH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ZBH shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ZBH shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$118.87
Based on 5.2% avg growth
INTRINSIC VALUE TODAY
$73.81
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ZBH is currently trading at $100.98, which is considered extended relative to its 30-day fair value range of $91.41 to $98.74. The stock's valuation (Forward PE: 11.1) is in line with its historical norms (10.2). At these levels, the market is pricing in 2.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ZBH is in a uptrend. The price is approaching resistance at $101.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ZBH scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZBH is in a uptrend. The price is approaching resistance at $101.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ZBH scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$91.41 -
$98.74
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
24.8%
Protect Your Profits
Holding ZBH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (22/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($107.57)
- NEUTRAL: Market pricing in 2.8% annual earnings growth - fairly valued
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$91.41 -
$98.74
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$94.28
Resistance Level
$101.95
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.11
Wall Street Target
$107.57
(+6.8%)
Revenue Growth (YoY)
4.8%
Earnings Growth (YoY)
33.8%
Profit Margin
9.5%
Valuation Premium vs History
+2.8% premium
PE vs Historical
11.1 vs 10.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.8%
(market-implied from PE analysis)
1-Year Target
$103.56
(+3%)
2-Year Target
$106.46
(+6%)
3-Year Target
$109.44
(+9%)
3-Yr Target (if PE normalizes)
(PE: 11→10)
PE COMPRESSION
$100.47
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 6.3%)
$218.29
(+117%)
Base:
(SPY PE: 11.1, Growth: 6.3%)
$120.84
(+20%)
Bear:
(PE: 9.4, Growth: 6.3%)
$102.71
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 23.83 | Current EPS (TTM): $4.16
Bull Case
$218.13
(+116%)
Analyst growth 100.0%, PE expands to 26.2
Base Case
$198.30
(+96%)
Market implied 100.0%, PE stable at 23.8
Bear Case
$67.42
(-33%)
Severe decline -20.0%, PE contracts to 20.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 22, 2026 11:50 AM ET
Data refreshes hourly during market hours. Next update: 12:50 PM
Data refreshes hourly during market hours. Next update: 12:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZBH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-23
Lori Winkler
SELL
2650 shares
2026-03-12
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 37 SELL |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 49 HOLD |
Advanced ZBH Option Strategies
Professional options setups generated by AI based on today's ZBH price and gamma walls.
